Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow-to-Debt Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow-to-Debt Ratio of 0.28x as of March 2026, meaning its operating cash flow of TL180.45 Million could theoretically repay 0% of its total liabilities (TL648.60 Million) in one year. Check total reinvestment intensity of Meditera Tibbi Malzeme Sanayi ve Ticaret to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Also explore total assets of Meditera Tibbi Malzeme Sanayi ve Ticaret for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year debt coverage analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For market capitalisation and broader financial context, see Meditera Tibbi Malzeme Sanayi ve Ticaret stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | TL435.35 Million | TL661.10 Million | ▼ -36.5% |
| 2024 | 1.04x | TL780.69 Million | TL752.75 Million | ▼ -22.8% |
| 2023 | 1.34x | TL801.02 Million | TL596.54 Million | ▲ +5492.3% |
| 2022 | 0.02x | TL5.10 Million | TL212.41 Million | ▼ -90.2% |
| 2021 | 0.24x | TL36.64 Million | TL149.84 Million | ▼ -58.4% |
| 2020 | 0.59x | TL73.26 Million | TL124.53 Million | ▲ +175.6% |
| 2019 | 0.21x | TL20.01 Million | TL93.72 Million | ▼ -72.2% |
| 2018 | 0.77x | TL73.26 Million | TL95.36 Million | — |